Serveur d'exploration sur la rapamycine et les champignons

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Suppression of CYP1 members of the AHR response by pathogen-associated molecular patterns.

Identifieur interne : 000736 ( Main/Exploration ); précédent : 000735; suivant : 000737

Suppression of CYP1 members of the AHR response by pathogen-associated molecular patterns.

Auteurs : Adam G. Peres [Canada] ; Robert Zamboni [Canada] ; Irah L. King [Canada] ; Joaquín Madrenas [Canada, États-Unis]

Source :

RBID : pubmed:29018148

Descripteurs français

English descriptors

Abstract

The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that triggers a broad response, which includes the regulation of proinflammatory cytokine production by monocytes and macrophages. AHR is negatively regulated by a set of genes that it transcriptionally activates, including the AHR repressor (Ahrr) and the cytochrome P450 1 (Cyp1) family, which are critical for preventing exacerbated AHR activity. An imbalance in these regulatory mechanisms has been shown to cause severe defects in lymphoid cells. Therefore, we wanted to assess how AHR activation is regulated in monocytes and macrophages in the context of innate immune responses induced by pathogen-associated molecular patterns (PAMPs). We found that concomitant stimulation of primary human monocytes with PAMPs and the AHR agonist 6-formylindolo(3,2-b)carbazole (FICZ) led to a selective dose-dependent inhibition of Cyp1 family members induction. Two other AHR-dependent genes [Ahrr and NADPH quinone dehydrogenase 1 (Nqo1)] were not affected under these conditions, suggesting a split in the AHR regulation by PAMPs. This down-regulation of Cyp1 family members did not require de novo protein production nor signaling through p38, ERK, or PI3K-Akt-mammalian target of rapamycin (mTOR) pathways. Furthermore, such a split regulation of the AHR response was more apparent in GM-CSF-derived macrophages, a finding corroborated at the functional level by decreased CYP1 activity and decreased proinflammatory cytokine production in response to FICZ and LPS. Collectively, our findings identify a role for pattern recognition receptor (PRR) signaling in regulating the AHR response through selective down-regulation of Cyp1 expression in human monocytes and macrophages.

DOI: 10.1189/jlb.4A0617-218RR
PubMed: 29018148


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Suppression of CYP1 members of the AHR response by pathogen-associated molecular patterns.</title>
<author>
<name sortKey="Peres, Adam G" sort="Peres, Adam G" uniqKey="Peres A" first="Adam G" last="Peres">Adam G. Peres</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology and Immunology, Microbiome and Disease Tolerance Centre, McGill University, Montréal, Quebec, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Microbiology and Immunology, Microbiome and Disease Tolerance Centre, McGill University, Montréal, Quebec</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zamboni, Robert" sort="Zamboni, Robert" uniqKey="Zamboni R" first="Robert" last="Zamboni">Robert Zamboni</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Chemistry, McGill University, Montréal, Quebec, Canada; and.</nlm:affiliation>
<orgName type="university">Université McGill</orgName>
<country>Canada</country>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="King, Irah L" sort="King, Irah L" uniqKey="King I" first="Irah L" last="King">Irah L. King</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology and Immunology, Microbiome and Disease Tolerance Centre, McGill University, Montréal, Quebec, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Microbiology and Immunology, Microbiome and Disease Tolerance Centre, McGill University, Montréal, Quebec</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Madrenas, Joaquin" sort="Madrenas, Joaquin" uniqKey="Madrenas J" first="Joaquín" last="Madrenas">Joaquín Madrenas</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology and Immunology, Microbiome and Disease Tolerance Centre, McGill University, Montréal, Quebec, Canada; joaquin.madrenas@labiomed.org.</nlm:affiliation>
<orgName type="university">Université McGill</orgName>
<country>Canada</country>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
<affiliation wicri:level="2">
<nlm:affiliation>Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:29018148</idno>
<idno type="pmid">29018148</idno>
<idno type="doi">10.1189/jlb.4A0617-218RR</idno>
<idno type="wicri:Area/Main/Corpus">000706</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000706</idno>
<idno type="wicri:Area/Main/Curation">000706</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000706</idno>
<idno type="wicri:Area/Main/Exploration">000706</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Suppression of CYP1 members of the AHR response by pathogen-associated molecular patterns.</title>
<author>
<name sortKey="Peres, Adam G" sort="Peres, Adam G" uniqKey="Peres A" first="Adam G" last="Peres">Adam G. Peres</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology and Immunology, Microbiome and Disease Tolerance Centre, McGill University, Montréal, Quebec, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Microbiology and Immunology, Microbiome and Disease Tolerance Centre, McGill University, Montréal, Quebec</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zamboni, Robert" sort="Zamboni, Robert" uniqKey="Zamboni R" first="Robert" last="Zamboni">Robert Zamboni</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Chemistry, McGill University, Montréal, Quebec, Canada; and.</nlm:affiliation>
<orgName type="university">Université McGill</orgName>
<country>Canada</country>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="King, Irah L" sort="King, Irah L" uniqKey="King I" first="Irah L" last="King">Irah L. King</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology and Immunology, Microbiome and Disease Tolerance Centre, McGill University, Montréal, Quebec, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Microbiology and Immunology, Microbiome and Disease Tolerance Centre, McGill University, Montréal, Quebec</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Madrenas, Joaquin" sort="Madrenas, Joaquin" uniqKey="Madrenas J" first="Joaquín" last="Madrenas">Joaquín Madrenas</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Microbiology and Immunology, Microbiome and Disease Tolerance Centre, McGill University, Montréal, Quebec, Canada; joaquin.madrenas@labiomed.org.</nlm:affiliation>
<orgName type="university">Université McGill</orgName>
<country>Canada</country>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
<affiliation wicri:level="2">
<nlm:affiliation>Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of leukocyte biology</title>
<idno type="eISSN">1938-3673</idno>
<imprint>
<date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Carbazoles (pharmacology)</term>
<term>Cell Differentiation (drug effects)</term>
<term>Cells, Cultured (MeSH)</term>
<term>Cytochrome P-450 CYP1A1 (biosynthesis)</term>
<term>Cytochrome P-450 CYP1A1 (metabolism)</term>
<term>Enzyme Induction (drug effects)</term>
<term>Granulocyte-Macrophage Colony-Stimulating Factor (pharmacology)</term>
<term>Humans (MeSH)</term>
<term>Ligands (MeSH)</term>
<term>Lipopolysaccharides (pharmacology)</term>
<term>Macrophages (cytology)</term>
<term>Macrophages (drug effects)</term>
<term>Macrophages (metabolism)</term>
<term>Monocytes (cytology)</term>
<term>Pathogen-Associated Molecular Pattern Molecules (metabolism)</term>
<term>Receptors, Aryl Hydrocarbon (metabolism)</term>
<term>Signal Transduction (drug effects)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Carbazoles (pharmacologie)</term>
<term>Cellules cultivées (MeSH)</term>
<term>Cytochrome P-450 CYP1A1 (biosynthèse)</term>
<term>Cytochrome P-450 CYP1A1 (métabolisme)</term>
<term>Différenciation cellulaire (effets des médicaments et des substances chimiques)</term>
<term>Facteur de stimulation des colonies de granulocytes et de macrophages (pharmacologie)</term>
<term>Humains (MeSH)</term>
<term>Induction enzymatique (effets des médicaments et des substances chimiques)</term>
<term>Ligands (MeSH)</term>
<term>Lipopolysaccharides (pharmacologie)</term>
<term>Macrophages (cytologie)</term>
<term>Macrophages (effets des médicaments et des substances chimiques)</term>
<term>Macrophages (métabolisme)</term>
<term>Molécules contenant des motifs associés aux pathogènes (métabolisme)</term>
<term>Monocytes (cytologie)</term>
<term>Récepteurs à hydrocarbure aromatique (métabolisme)</term>
<term>Transduction du signal (effets des médicaments et des substances chimiques)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>Cytochrome P-450 CYP1A1</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Cytochrome P-450 CYP1A1</term>
<term>Pathogen-Associated Molecular Pattern Molecules</term>
<term>Receptors, Aryl Hydrocarbon</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Carbazoles</term>
<term>Granulocyte-Macrophage Colony-Stimulating Factor</term>
<term>Lipopolysaccharides</term>
</keywords>
<keywords scheme="MESH" qualifier="biosynthèse" xml:lang="fr">
<term>Cytochrome P-450 CYP1A1</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr">
<term>Macrophages</term>
<term>Monocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en">
<term>Macrophages</term>
<term>Monocytes</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Cell Differentiation</term>
<term>Enzyme Induction</term>
<term>Macrophages</term>
<term>Signal Transduction</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr">
<term>Différenciation cellulaire</term>
<term>Induction enzymatique</term>
<term>Macrophages</term>
<term>Transduction du signal</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Macrophages</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Cytochrome P-450 CYP1A1</term>
<term>Macrophages</term>
<term>Molécules contenant des motifs associés aux pathogènes</term>
<term>Récepteurs à hydrocarbure aromatique</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Carbazoles</term>
<term>Facteur de stimulation des colonies de granulocytes et de macrophages</term>
<term>Lipopolysaccharides</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Cells, Cultured</term>
<term>Humans</term>
<term>Ligands</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Cellules cultivées</term>
<term>Humains</term>
<term>Ligands</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that triggers a broad response, which includes the regulation of proinflammatory cytokine production by monocytes and macrophages. AHR is negatively regulated by a set of genes that it transcriptionally activates, including the AHR repressor (
<i>Ahrr</i>
) and the cytochrome P450 1 (
<i>Cyp1</i>
) family, which are critical for preventing exacerbated AHR activity. An imbalance in these regulatory mechanisms has been shown to cause severe defects in lymphoid cells. Therefore, we wanted to assess how AHR activation is regulated in monocytes and macrophages in the context of innate immune responses induced by pathogen-associated molecular patterns (PAMPs). We found that concomitant stimulation of primary human monocytes with PAMPs and the AHR agonist 6-formylindolo(3,2-b)carbazole (FICZ) led to a selective dose-dependent inhibition of
<i>Cyp1</i>
family members induction. Two other AHR-dependent genes [
<i>Ahrr</i>
and NADPH quinone dehydrogenase 1 (
<i>Nqo1</i>
)] were not affected under these conditions, suggesting a split in the AHR regulation by PAMPs. This down-regulation of
<i>Cyp1</i>
family members did not require de novo protein production nor signaling through p38, ERK, or PI3K-Akt-mammalian target of rapamycin (mTOR) pathways. Furthermore, such a split regulation of the AHR response was more apparent in GM-CSF-derived macrophages, a finding corroborated at the functional level by decreased CYP1 activity and decreased proinflammatory cytokine production in response to FICZ and LPS. Collectively, our findings identify a role for pattern recognition receptor (PRR) signaling in regulating the AHR response through selective down-regulation of
<i>Cyp1</i>
expression in human monocytes and macrophages.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">29018148</PMID>
<DateCompleted>
<Year>2017</Year>
<Month>12</Month>
<Day>12</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>10</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1938-3673</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>102</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2017</Year>
<Month>12</Month>
</PubDate>
</JournalIssue>
<Title>Journal of leukocyte biology</Title>
<ISOAbbreviation>J Leukoc Biol</ISOAbbreviation>
</Journal>
<ArticleTitle>Suppression of CYP1 members of the AHR response by pathogen-associated molecular patterns.</ArticleTitle>
<Pagination>
<MedlinePgn>1471-1480</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1189/jlb.4A0617-218RR</ELocationID>
<Abstract>
<AbstractText>The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor that triggers a broad response, which includes the regulation of proinflammatory cytokine production by monocytes and macrophages. AHR is negatively regulated by a set of genes that it transcriptionally activates, including the AHR repressor (
<i>Ahrr</i>
) and the cytochrome P450 1 (
<i>Cyp1</i>
) family, which are critical for preventing exacerbated AHR activity. An imbalance in these regulatory mechanisms has been shown to cause severe defects in lymphoid cells. Therefore, we wanted to assess how AHR activation is regulated in monocytes and macrophages in the context of innate immune responses induced by pathogen-associated molecular patterns (PAMPs). We found that concomitant stimulation of primary human monocytes with PAMPs and the AHR agonist 6-formylindolo(3,2-b)carbazole (FICZ) led to a selective dose-dependent inhibition of
<i>Cyp1</i>
family members induction. Two other AHR-dependent genes [
<i>Ahrr</i>
and NADPH quinone dehydrogenase 1 (
<i>Nqo1</i>
)] were not affected under these conditions, suggesting a split in the AHR regulation by PAMPs. This down-regulation of
<i>Cyp1</i>
family members did not require de novo protein production nor signaling through p38, ERK, or PI3K-Akt-mammalian target of rapamycin (mTOR) pathways. Furthermore, such a split regulation of the AHR response was more apparent in GM-CSF-derived macrophages, a finding corroborated at the functional level by decreased CYP1 activity and decreased proinflammatory cytokine production in response to FICZ and LPS. Collectively, our findings identify a role for pattern recognition receptor (PRR) signaling in regulating the AHR response through selective down-regulation of
<i>Cyp1</i>
expression in human monocytes and macrophages.</AbstractText>
<CopyrightInformation>© Society for Leukocyte Biology.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Peres</LastName>
<ForeName>Adam G</ForeName>
<Initials>AG</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Immunology, Microbiome and Disease Tolerance Centre, McGill University, Montréal, Quebec, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zamboni</LastName>
<ForeName>Robert</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Chemistry, McGill University, Montréal, Quebec, Canada; and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>King</LastName>
<ForeName>Irah L</ForeName>
<Initials>IL</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Immunology, Microbiome and Disease Tolerance Centre, McGill University, Montréal, Quebec, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Madrenas</LastName>
<ForeName>Joaquín</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Department of Microbiology and Immunology, Microbiome and Disease Tolerance Centre, McGill University, Montréal, Quebec, Canada; joaquin.madrenas@labiomed.org.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<Agency>CIHR</Agency>
<Country>Canada</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2017</Year>
<Month>10</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Leukoc Biol</MedlineTA>
<NlmUniqueID>8405628</NlmUniqueID>
<ISSNLinking>0741-5400</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C111855">6-formylindolo(3,2-b)carbazole</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002227">Carbazoles</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008024">Ligands</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000069452">Pathogen-Associated Molecular Pattern Molecules</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018336">Receptors, Aryl Hydrocarbon</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>83869-56-1</RegistryNumber>
<NameOfSubstance UI="D016178">Granulocyte-Macrophage Colony-Stimulating Factor</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.14.14.1</RegistryNumber>
<NameOfSubstance UI="C569463">CYP1A1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 1.14.14.1</RegistryNumber>
<NameOfSubstance UI="D019363">Cytochrome P-450 CYP1A1</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D002227" MajorTopicYN="N">Carbazoles</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019363" MajorTopicYN="N">Cytochrome P-450 CYP1A1</DescriptorName>
<QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D016178" MajorTopicYN="N">Granulocyte-Macrophage Colony-Stimulating Factor</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000069452" MajorTopicYN="N">Pathogen-Associated Molecular Pattern Molecules</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018336" MajorTopicYN="N">Receptors, Aryl Hydrocarbon</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">GM-CSF</Keyword>
<Keyword MajorTopicYN="Y">human</Keyword>
<Keyword MajorTopicYN="Y">macrophages</Keyword>
<Keyword MajorTopicYN="Y">monocytes</Keyword>
<Keyword MajorTopicYN="Y">pattern recognition receptors</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2017</Year>
<Month>06</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2017</Year>
<Month>09</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2017</Year>
<Month>09</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2017</Year>
<Month>10</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2017</Year>
<Month>12</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2017</Year>
<Month>10</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">29018148</ArticleId>
<ArticleId IdType="pii">jlb.4A0617-218RR</ArticleId>
<ArticleId IdType="doi">10.1189/jlb.4A0617-218RR</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Canada</li>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
<li>Québec</li>
</region>
<settlement>
<li>Montréal</li>
</settlement>
<orgName>
<li>Université McGill</li>
</orgName>
</list>
<tree>
<country name="Canada">
<region name="Québec">
<name sortKey="Peres, Adam G" sort="Peres, Adam G" uniqKey="Peres A" first="Adam G" last="Peres">Adam G. Peres</name>
</region>
<name sortKey="King, Irah L" sort="King, Irah L" uniqKey="King I" first="Irah L" last="King">Irah L. King</name>
<name sortKey="Madrenas, Joaquin" sort="Madrenas, Joaquin" uniqKey="Madrenas J" first="Joaquín" last="Madrenas">Joaquín Madrenas</name>
<name sortKey="Zamboni, Robert" sort="Zamboni, Robert" uniqKey="Zamboni R" first="Robert" last="Zamboni">Robert Zamboni</name>
</country>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Madrenas, Joaquin" sort="Madrenas, Joaquin" uniqKey="Madrenas J" first="Joaquín" last="Madrenas">Joaquín Madrenas</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000736 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000736 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:29018148
   |texte=   Suppression of CYP1 members of the AHR response by pathogen-associated molecular patterns.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:29018148" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a RapamycinFungusV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020